Cost–Benefit Analysis of Interventions to Mitigate the Monkeypox Virus
Abstract
:1. Introduction
2. Research Method
2.1. Research Objective
2.2. Research Questions
2.3. Research Methodology
3. Results
3.1. The Cost of Not Implementing Any Intervention
day (cpd),
rate (tr) × number of total contacts per day (cpd),
1.5376
3.1.1. Cost of Mortality
3.1.2. Cost of Work Absenteeism
3.2. The Net Cost of Quarantine
3.3. Direct Costs
3.4. Indirect Costs
3.4.1. Cost of Mortality
3.4.2. Cost of Work Absenteeism
3.5. The Net Cost of Vaccination
3.5.1. Direct Costs
3.5.2. Indirect Costs
4. Discussion
5. Conclusion
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Pekarsky, M. City, State Public Health Officials Confirm First Probable Case of Monkeypox Virus in Missouri. Missouri Department of Health and Senior Services, 2022. Available online: https://health.mo.gov/news/newsitem/uuid/2e7e061d-6f80-4e84-a278-cfb9ce6f23c1/city-state-public-health-officials-confirm-first-probable-case-of-Monkeypox-virus-in-missouri#:~:text=On%20May%2018%2C%202022%2C%20a,orthopox%2FMonkeypox%20across%20multiple%20states (accessed on 24 August 2022).
- Reuters. Factbox: Monkeypox Cases around the World. 2022. Available online: https://www.reuters.com/business/healthcare-pharmaceuticals/Monkeypox-cases-around-world-2022-05-23/ (accessed on 24 August 2022).
- Centers for Disease Control and Prevention, CDC. Transmission. 2016. Available online: https://www.cdc.gov/smallpox/clinicians/transmission.html#:~:text=A%20person%20is%20considered%20at,approximately%2060%25%20among%20unvaccinated%20individuals (accessed on 24 August 2022).
- Di Giulio, D.B.; Eckburg, P.B. Human Monkeypox: An emerging zoonosis. Lancet Infect. Dis. 2004, 4, 15–25. [Google Scholar] [CrossRef]
- The World Health Organization (WHO). Multi-Country Monkeypox Outbreak: Situation Update. 2022. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392#:~:text=Since%20the%20beginning%20of%202022,same%20period%20(Table%202) (accessed on 24 August 2022).
- Thornhill, J.P.; Barkati, S.; Walmsley, S.; Rockstroh, J.; Antinori, A.; Harrison, L.B.; Orkin, C.M. Monkeypox virus infection in humans across 16 countries—April–June 2022. N. Engl. J. Med. 2022, 387, 679–691. [Google Scholar] [CrossRef] [PubMed]
- Mahase, E. Monkeypox: Gay and bisexual men with high exposure risk will be offered vaccine in England. Bmj 2022, 377, o1542. [Google Scholar] [CrossRef] [PubMed]
- Vaughan, A.; Aarons, E.; Astbury, J.; Brooks, T.; Chand, M.; Flegg, P.; Dunning, J. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018. Emerg. Infect. Dis. 2020, 26, 782. [Google Scholar] [CrossRef] [PubMed]
- Rizk, J.G.; Lippi, G.; Henry, B.M.; Forthal, D.N.; Rizk, Y. Prevention and treatment of monkeypox. Drugs 2022, 82, 957–963. [Google Scholar] [CrossRef] [PubMed]
- Leung, K.; Jit, M.; Lau, E.H.; Wu, J.T. Social contact patterns relevant to the spread of respiratory infectious diseases in Hong Kong. Sci. Rep. 2017, 7, 1–12. [Google Scholar] [CrossRef]
- Gavrilova, N.S.; Gavrilov, L.A. Patterns of mortality during pandemic: An example of Spanish flu pandemic of 1918. Popul. Econ. 2020, 4, 56. [Google Scholar] [CrossRef]
- Flecknoe, D.; Charles, W.B.; Simmons, A. Plagues & wars: The ‘Spanish Flu’ pandemic as a lesson from history. Med. Confl. Surviv. 2018, 34, 61–68. [Google Scholar]
- More, A.F.; Loveluck, C.P.; Clifford, H.; Handley, M.J.; Korotkikh, E.V.; Kurbatov, A.V.; Mayewski, P.A. The impact of a six-year climate anomaly on the “Spanish flu” pandemic and WWI. GeoHealth 2020, 4, e2020GH000277. [Google Scholar] [CrossRef]
- Tsoucalas, G.; Kousoulis, A.; Sgantzos, M. The 1918 Spanish Flu Pandemic, the origins of the H1N1-virus strain, a glance in history. Eur. J. Clin. Biomed. Sci. 2016, 2, 23. [Google Scholar]
- Mazumder, B.; Almond, D.; Park, K.; Crimmins, E.M.; Finch, C.E. Lingering prenatal effects of the 1918 influenza pandemic on cardiovascular disease. J. Dev. Orig. Health Dis. 2010, 1, 26–34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Beach, B.; Clay, K.; Saavedra, M. The 1918 influenza pandemic and its lessons for COVID-19. J. Econ. Lit. 2022, 60, 41–84. [Google Scholar] [CrossRef]
- Almond, D.; Mazumder, B. The 1918 influenza pandemic and subsequent health outcomes: An analysis of SIPP data. Am. Econ. Rev. 2005, 95, 258–262. [Google Scholar] [CrossRef] [PubMed]
- Velde, F.R. What happened to the US economy during the 1918 influenza pandemic? A view through high-frequency data. J. Econ. Hist. 2022, 82, 284–326. [Google Scholar] [CrossRef]
- Garrett, T.A. Economic Effects of the 1918 Influenza Pandemic; Federal Reserve Bank of St. Louis: St. Louis, MO, USA, 2007; p. 26. [Google Scholar]
- Benmelech, E.; Frydman, C. The 1918 influenza did not kill the US economy. In VOX CEPR Policy Portal; 2020; p. 29. Available online: https://cepr.org/voxeu/columns/1918-influenza-did-not-kill-us-economy (accessed on 20 August 2022).
- Barro, R.J.; Ursúa, J.F.; Weng, J. The Coronavirus and the Great Influenza Pandemic: Lessons from the “Spanish Flu” for the Coronavirus’s Potential Effects on Mortality and Economic Activity (No. w26866); National Bureau of Economic Research: Cambridge, MA, USA, 2020. [Google Scholar]
- Correia, S.; Luck, S.; Verner, E. Pandemics depress the economy, public health interventions do not: Evidence from the 1918 flu. arXiv 2022, arXiv:2207.11636. [Google Scholar] [CrossRef]
- Deb, P.; Furceri, D.; Ostry, J.D.; Tawk, N. The economic effects of COVID-19 containment measures. Open Econ. Rev. 2020, 33, 1–32. [Google Scholar] [CrossRef]
- Pak, A.; Adegboye, O.A.; Adekunle, A.I.; Rahman, K.M.; McBryde, E.S.; Eisen, D.P. Economic consequences of the COVID-19 outbreak: The need for epidemic preparedness. Front. Public Health 2020, 8, 241. [Google Scholar] [CrossRef]
- Nicola, M.; Alsafi, Z.; Sohrabi, C.; Kerwan, A.; Al-Jabir, A.; Iosifidis, C.; Agha, R. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int. J. Surg. 2020, 78, 185–193. [Google Scholar] [CrossRef]
- Gupta, A.G.; Moyer, C.A.; Stern, D.T. The economic impact of quarantine: SARS in Toronto as a case study. J. Infect. 2005, 50, 386–393. [Google Scholar] [CrossRef]
- Wang, H.; Jin, H.; Li, X.; Zheng, W.; Ye, S.; Zhang, S.; Zhou, J.; Pennington, M. Economic burden of COVID-19, China, January–March, 2020: A cost-of-illness study. Bull. World Health Organ. 2021, 99, 112–124. [Google Scholar] [CrossRef]
- Gilchrist, K. CDC Raises Monkeypox Alert as Global Cases Surpass 1000. CNBC, 2022. Available online: https://www.cnbc.com/2022/06/07/cdc-raises-monkeypoxMonkeypox-alert-as-global-cases-surpass-1000.html (accessed on 17 August 2022).
- The U.S. Food and Drug Administration, FDA. FDA Approves First Live, Non-Replicating Vaccine to Prevent Smallpox and Monkeypox. 2019. Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypoxMonkeypox#:~:text=The%20U.S.%20Food%20and%20Drug,for%20smallpox%20or%20monkeypoxMonkeypox%20infection (accessed on 21 August 2022).
- Hutubessy, R.; Chisholm, D.; Edejer, T.T.T. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff. Resour. Alloc. 2003, 1, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jezek, Z.; Grab, B.; Szczeniowski, M.V.; Paluku, K.M.; Mutombo, M. Human Monkeypox: Secondary attack rates. Bull. World Health Organ. 1988, 66, 465. [Google Scholar] [PubMed]
- Ceic Data. Saudi Arabia GDP per Capita. 2022. Available online: https://www.ceicdata.com/en/indicator/saudi-arabia/gdp-per-capita (accessed on 22 August 2022).
- Worldometers. Saudi Arabia Population (LIVE). 2022. Available online: https://www.worldometers.info/world-population/saudi-arabia-population/#:~:text=The%20median%20age%20in%20Saudi%20Arabia%20is%2031.8%20years (accessed on 24 August 2022).
- Marshall, P. The impact of quarantine on Covid-19 infections. Epidemiol. Methods 2021, 10, 1–8. [Google Scholar] [CrossRef]
- Conti, R. Smallpox vaccinations: The risks and the benefits. Issue Brief (Commonw. Fund) 2003, 620, 1–7. [Google Scholar]
Day | Transmission Rate | Default Contacts | Previous Infections | Total Contacts | New Infections | Number of Total Infections |
---|---|---|---|---|---|---|
1 | 0.03 | 8 | 1 | 8 | 0.24 | 1.24 |
2 | 0.03 | 8 | 1.24 | 9.92 | 0.2976 | 1.5376 |
3 | 0.03 | 8 | 1.5376 | 12.3008 | 0.369024 | 1.906624 |
4 | 0.03 | 8 | 1.906624 | 15.252992 | 0.45758976 | 2.36421376 |
5 | 0.03 | 8 | 2.36421376 | 18.91371008 | 0.567411302 | 2.931625062 |
6 | 0.03 | 8 | 2.931625062 | 23.4530005 | 0.703590015 | 3.635215077 |
7 | 0.03 | 8 | 3.635215077 | 29.08172062 | 0.872451619 | 4.507666696 |
8 | 0.03 | 8 | 4.507666696 | 36.06133357 | 1.081840007 | 5.589506703 |
9 | 0.03 | 8 | 5.589506703 | 44.71605362 | 1.341481609 | 6.930988312 |
10 | 0.03 | 8 | 6.930988312 | 55.44790649 | 1.663437195 | 8.594425506 |
11 | 0.03 | 8 | 8.594425506 | 68.75540405 | 2.062662122 | 10.65708763 |
12 | 0.03 | 8 | 10.65708763 | 85.25670102 | 2.557701031 | 13.21478866 |
13 | 0.03 | 8 | 13.21478866 | 105.7183093 | 3.171549278 | 16.38633794 |
14 | 0.03 | 8 | 16.38633794 | 131.0907035 | 3.932721105 | 20.31905904 |
15 | 0.03 | 8 | 20.31905904 | 162.5524723 | 4.87657417 | 25.19563321 |
16 | 0.03 | 8 | 25.19563321 | 201.5650657 | 6.046951971 | 31.24258518 |
17 | 0.03 | 8 | 31.24258518 | 249.9406815 | 7.498220444 | 38.74080563 |
18 | 0.03 | 8 | 38.74080563 | 309.926445 | 9.29779335 | 48.03859898 |
19 | 0.03 | 8 | 48.03859898 | 384.3087918 | 11.52926375 | 59.56786273 |
20 | 0.03 | 8 | 59.56786273 | 476.5429018 | 14.29628706 | 73.86414979 |
21 | 0.03 | 8 | 73.86414979 | 590.9131983 | 17.72739595 | 91.59154574 |
22 | 0.03 | 8 | 91.59154574 | 732.7323659 | 21.98197098 | 113.5735167 |
23 | 0.03 | 8 | 113.5735167 | 908.5881337 | 27.25764401 | 140.8311607 |
24 | 0.03 | 8 | 140.8311607 | 1126.649286 | 33.79947857 | 174.6306393 |
25 | 0.03 | 8 | 174.6306393 | 1397.045114 | 41.91135343 | 216.5419927 |
26 | 0.03 | 8 | 216.5419927 | 1732.335942 | 51.97007825 | 268.512071 |
27 | 0.03 | 8 | 268.512071 | 2148.096568 | 64.44289704 | 332.954968 |
28 | 0.03 | 8 | 332.954968 | 2663.639744 | 79.90919232 | 412.8641603 |
Day | Transmission Rate | Default Contacts | Previous Infections | Total Contacts | New Infections | Number of Total Infections |
---|---|---|---|---|---|---|
1 | 0.02253 | 8 | 1 | 8 | 0.18024 | 1.18024 |
2 | 0.02253 | 8 | 1.18024 | 9.44192 | 0.212726458 | 1.392966458 |
3 | 0.02253 | 8 | 1.392966458 | 11.14373166 | 0.251068274 | 1.644034732 |
4 | 0.02253 | 8 | 1.644034732 | 13.15227786 | 0.29632082 | 1.940355552 |
5 | 0.02253 | 8 | 1.940355552 | 15.52284442 | 0.349729685 | 2.290085237 |
6 | 0.02253 | 8 | 2.290085237 | 18.32068189 | 0.412764963 | 2.7028502 |
7 | 0.02253 | 8 | 2.7028502 | 21.6228016 | 0.48716172 | 3.19001192 |
8 | 0.02253 | 8 | 3.19001192 | 25.52009536 | 0.574967748 | 3.764979668 |
9 | 0.02253 | 8 | 3.764979668 | 30.11983735 | 0.678599935 | 4.443579604 |
10 | 0.02253 | 8 | 4.443579604 | 35.54863683 | 0.800910788 | 5.244490391 |
11 | 0.02253 | 8 | 5.244490391 | 41.95592313 | 0.945266948 | 6.189757339 |
12 | 0.02253 | 8 | 6.189757339 | 49.51805872 | 1.115641863 | 7.305399202 |
13 | 0.02253 | 8 | 7.305399202 | 58.44319362 | 1.316725152 | 8.622124355 |
14 | 0.02253 | 8 | 8.622124355 | 68.97699484 | 1.554051694 | 10.17617605 |
15 | 0.02253 | 8 | 10.17617605 | 81.40940839 | 1.834153971 | 12.01033002 |
16 | 0.02253 | 8 | 12.01033002 | 96.08264015 | 2.164741883 | 14.1750719 |
17 | 0.02253 | 8 | 14.1750719 | 113.4005752 | 2.55491496 | 16.72998686 |
18 | 0.02253 | 8 | 16.72998686 | 133.8398949 | 3.015412832 | 19.74539969 |
19 | 0.02253 | 8 | 19.74539969 | 157.9631975 | 3.558910841 | 23.30431053 |
20 | 0.02253 | 8 | 23.30431053 | 186.4344843 | 4.200368931 | 27.50467946 |
21 | 0.02253 | 8 | 27.50467946 | 220.0374357 | 4.957443427 | 32.46212289 |
22 | 0.02253 | 8 | 32.46212289 | 259.6969831 | 5.85097303 | 38.31309592 |
23 | 0.02253 | 8 | 38.31309592 | 306.5047674 | 6.905552409 | 45.21864833 |
24 | 0.02253 | 8 | 45.21864833 | 361.7491866 | 8.150209175 | 53.3688575 |
25 | 0.02253 | 8 | 53.3688575 | 426.95086 | 9.619202877 | 62.98806038 |
26 | 0.02253 | 8 | 62.98806038 | 503.9044831 | 11.352968 | 74.34102838 |
27 | 0.02253 | 8 | 74.34102838 | 594.7282271 | 13.39922696 | 87.74025534 |
28 | 0.02253 | 8 | 87.74025534 | 701.9220427 | 15.81430362 | 103.554559 |
Day | Transmission Rate | Default Contacts | Previous Infections | Total Contacts | New Infections | Number of Total Infections |
---|---|---|---|---|---|---|
1 | 0.0045 | 8 | 1 | 8 | 0.036 | 1.036 |
2 | 0.0045 | 8 | 1.036 | 8.288 | 0.037296 | 1.073296 |
3 | 0.0045 | 8 | 1.073296 | 8.586368 | 0.038638656 | 1.111934656 |
4 | 0.0045 | 8 | 1.111934656 | 8.895477248 | 0.040029648 | 1.151964304 |
5 | 0.0045 | 8 | 1.151964304 | 9.215714429 | 0.041470715 | 1.193435019 |
6 | 0.0045 | 8 | 1.193435019 | 9.547480148 | 0.042963661 | 1.236398679 |
7 | 0.0045 | 8 | 1.236398679 | 9.891189434 | 0.044510352 | 1.280909032 |
8 | 0.0045 | 8 | 1.280909032 | 10.24727225 | 0.046112725 | 1.327021757 |
9 | 0.0045 | 8 | 1.327021757 | 10.61617405 | 0.047772783 | 1.37479454 |
10 | 0.0045 | 8 | 1.37479454 | 10.99835632 | 0.049492603 | 1.424287143 |
11 | 0.0045 | 8 | 1.424287143 | 11.39429715 | 0.051274337 | 1.475561481 |
12 | 0.0045 | 8 | 1.475561481 | 11.80449185 | 0.053120213 | 1.528681694 |
13 | 0.0045 | 8 | 1.528681694 | 12.22945355 | 0.055032541 | 1.583714235 |
14 | 0.0045 | 8 | 1.583714235 | 12.66971388 | 0.057013712 | 1.640727947 |
15 | 0.0045 | 8 | 1.640727947 | 13.12582358 | 0.059066206 | 1.699794154 |
16 | 0.0045 | 8 | 1.699794154 | 13.59835323 | 0.06119259 | 1.760986743 |
17 | 0.0045 | 8 | 1.760986743 | 14.08789394 | 0.063395523 | 1.824382266 |
18 | 0.0045 | 8 | 1.824382266 | 14.59505813 | 0.065677762 | 1.890060027 |
19 | 0.0045 | 8 | 1.890060027 | 15.12048022 | 0.068042161 | 1.958102188 |
20 | 0.0045 | 8 | 1.958102188 | 15.66481751 | 0.070491679 | 2.028593867 |
21 | 0.0045 | 8 | 2.028593867 | 16.22875094 | 0.073029379 | 2.101623246 |
22 | 0.0045 | 8 | 2.101623246 | 16.81298597 | 0.075658437 | 2.177281683 |
23 | 0.0045 | 8 | 2.177281683 | 17.41825347 | 0.078382141 | 2.255663824 |
24 | 0.0045 | 8 | 2.255663824 | 18.04531059 | 0.081203898 | 2.336867721 |
25 | 0.0045 | 8 | 2.336867721 | 18.69494177 | 0.084127238 | 2.420994959 |
26 | 0.0045 | 8 | 2.420994959 | 19.36795968 | 0.087155819 | 2.508150778 |
27 | 0.0045 | 8 | 2.508150778 | 20.06520622 | 0.090293428 | 2.598444206 |
28 | 0.0045 | 8 | 2.598444206 | 20.78755365 | 0.093543991 | 2.691988197 |
Intervention | Direct Costs (USD) | Infections (Mortality) | Mortality Cost | Productivity Loss | Indirect Cost | Total Costs |
---|---|---|---|---|---|---|
No Intervention | USD 0 | 413 (4) | USD 2,629,368 | USD 1,069,670 | USD 3,699,033 | USD 3,699,033 |
Quarantine | USD 161,200 | 5 (1) | USD 657,342 | USD 269,360 | USD 926,702 | 1,087,902 |
Vaccination | USD 36,000,000 | 3 (0) | USD 0 | USD 7770 | USD 7770 | USD 36,007,770 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
ALSHAHRANI, A.M. Cost–Benefit Analysis of Interventions to Mitigate the Monkeypox Virus. Int. J. Environ. Res. Public Health 2022, 19, 13789. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph192113789
ALSHAHRANI AM. Cost–Benefit Analysis of Interventions to Mitigate the Monkeypox Virus. International Journal of Environmental Research and Public Health. 2022; 19(21):13789. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph192113789
Chicago/Turabian StyleALSHAHRANI, Ali Mofleh. 2022. "Cost–Benefit Analysis of Interventions to Mitigate the Monkeypox Virus" International Journal of Environmental Research and Public Health 19, no. 21: 13789. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph192113789